Stay updated on REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial page.

Latest updates to the REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial page
- Check7 days agoChange DetectedThe study record for the REL-1017 Phase 3 trial is displayed, including its design, eligibility criteria, treatment arms, locations, outcome measures, publications, and record history.SummaryDifference49%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The site revision number also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check42 days agoChange DetectedThe site footer revision marker changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, blocking access to the study details. The previous content including study descriptions, locations, and related links is no longer visible due to the error.SummaryDifference17%

- Check63 days agoChange DetectedThe page's revision label updated to v3.7.0, replacing the previous v3.6.6, indicating an updated version of the related documentation or release notes.SummaryDifference0.1%

Stay in the know with updates to REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REL-1017 Adjunctive for MDD: Efficacy & Safety Clinical Trial page.